デジタル治療薬市場：コンポーネント別、用途別-2024-2030年の世界予測

デジタル治療薬市場規模は2023年に64億2,000万米ドルと推計され、2024年には80億5,000万米ドルに達し、CAGR 26.42％で2030年には331億6,000万米ドルに達すると予測されます。

DTxと略されるデジタル治療薬は、医療障害や疾病を予防、管理、治療するために設計されたソフトウェア主導の治療介入を網羅するデジタルヘルスの一分野を指します。デジタル治療薬は臨床的証拠に基づいて開発され、しばしば厳格な規制審査を受けます。デジタル治療薬は、単独で、または従来の治療と組み合わせて使用されることを意図しており、患者、ヘルスケアプロバイダー、支払者に、患者のケアと健康アウトカムを向上させるためのデータ主導型の個別化されたアプローチを提供します。デジタル治療薬市場は、慢性疾患の深刻化、医療費の上昇、ヘルスケア技術の進歩に伴って成長しています。スマートフォンの普及と遠隔医療サービスの受け入れも、この技術の採用に寄与しています。個別化された予防医療ソリューションへの需要が、市場の成長をさらに後押ししています。しかし、規制上のハードル、患者データのセキュリティへの懸念、デジタル治療アプリケーションの臨床検証の必要性など、市場はかなりの課題に直面しています。このような課題の中、デジタル治療薬と電子カルテ（EHR）の統合、AIと機械学習の可能性が、イノベーションとデジタル治療薬市場の将来の成長への道を開きます。

コンポーネントデータ分析ソフトウェアとコンプライアンス・サービスの重要性の高まり

デジタル治療薬に含まれるデバイスは、患者データを収集するウェアラブル、センサー、その他のタイプの生物医学的ハードウェアであることが多いです。これらのデバイスは、身体活動、睡眠パターン、血糖値など、さまざまな健康指標を追跡することができます。機器に対するニーズベースの嗜好は、使いやすさ、正確さ、ソフトウェア・アプリケーションとのシームレスな統合に傾いています。ソフトウェアとサービスは、デジタル治療薬の中核と見なされます。このセグメントは、治療的介入を提供するプラットフォーム、アプリケーション、専門的サービスで構成されます。ソフトウェアとサービスの拡張性、相互運用性、患者エンゲージメント、データセキュリティが優先されます。

アプリケーション：継続的な管理とモニタリングを必要とする糖尿病や慢性呼吸器疾患におけるデジタル治療薬の採用率が高いです。

心血管疾患を対象としたデジタル治療ソリューションには、心拍数、血圧、心血管健康関連の習慣をモニターするアプリケーションが含まれることが多いです。これらのソリューションに対するニーズは、心臓病の既往歴のある患者や、遺伝的要因やライフスタイルによってリスクのある患者で高いです。中枢神経系疾患アプリケーション・セグメントには、パーキンソン病、アルツハイマー病、うつ病、ADHDなどの疾患のデジタル治療薬が含まれます。ここでのDTxソリューションは、認知リハビリテーション、行動療法、投薬管理を目的としています。非薬理学的介入を求める人々の間では、ニーズに基づく選好が特に強いです。慢性呼吸器疾患におけるデジタル治療薬は、吸入器追跡、症状追跡、環境トリガーアラートなど、喘息やCOPD管理のためのツールを提供します。これらは、継続的なモニタリングが必要な患者や、疾患の増悪を管理したい患者に好まれています。糖尿病向けデジタルソリューションは、血糖値モニタリング、インスリン投与量トラッキング、ライフスタイルコーチングに重点を置いています。日々の管理とモニタリングの必要性から、糖尿病管理アプリの選好度は高いです。DTxの服薬アドヒアランス・アプリケーションは、患者が処方通りに薬を服用しないという課題に取り組むことを目的としています。このニーズは、すべての患者カテゴリーに共通していますが、慢性疾患の管理においては特に重要です。筋骨格系障害のデジタル治療薬は、運動プログラム、疼痛管理技術、理学療法ガイダンスを提供します。従来の治療から離れた、あるいは補完的な治療を求める患者に非常に好まれています。肥満に対するデジタル治療戦略には、個別化された栄養、身体活動の追跡、行動修正プログラムが含まれます。この分野のニーズは、世界の肥満率の上昇とそれに伴う健康リスクに牽引されています。糖尿病予備軍向けのデジタル治療薬は、2型糖尿病の発症を予防するためのライフスタイル介入に焦点を当てています。これらのアプリケーションは、糖尿病予備軍と判定された個人に対して、疾患の進行を遅らせたり予防したりするために有用です。禁煙のためのデジタル治療薬には、禁煙計画、進捗状況の追跡、カウンセリング支援が含まれます。これらのツールは禁煙を試みる人々の間で高い支持を得ており、しばしばニコチン代替療法を補完します。

地域別インサイト

南北アメリカでは、デジタル治療薬市場は、先進的な規制の枠組み、ベンチャーキャピタルからの多額の投資、DTx企業とヘルスケアプロバイダーとのパートナーシップの拡大に支えられ、堅調です。米国食品医薬品局（FDA）は、処方薬DTxの明確なガイダンスと承認を通じて、DTx製品のための環境を整えつつあり、これはこれらのソリューションを標準的なヘルスケアプラクティスに統合するための重要なステップとみなされています。欧州の市場情勢は、エビデンスに基づくソリューションが重視され、各国がDTxをヘルスケアシステムに組み込むために様々なアプローチを採用している多様なヘルスケア状況によって牽引されています。医師がデジタルヘルスアプリケーションを処方できるようにするドイツのデジタルヘルスケア法（DVG）のようなイニシアチブは、支援的な規制環境の一例です。中東とアフリカは、まだ初期段階にあるもの、主にモバイルベースのヘルスケア・イニシアチブとヘルスケア・サービスへのアクセス向上を目指すパートナーシップに後押しされ、成長が見込まれています。APAC地域は、経済的、文化的、技術的な準備態勢が異なるもの、デジタル治療薬にとって大きな可能性を示しています。日本やシンガポールを含む国々は、DTx導入の最前線にあり、デジタル・ヘルス・イノベーションのための有利な規制経路やイニシアティブを有しています。インドや中国のような他の地域では、スマートフォンの普及率の上昇とデジタルヘルスエコシステムを支援する政府の取り組みが、DTx拡大の機会を生み出しています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは、デジタル治療薬市場の評価において極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、デジタル治療薬市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力について徹底的な評価を行います。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1.デジタル治療薬市場の市場規模および予測は？

2.デジタル治療薬市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3.デジタル治療薬市場の技術動向と規制枠組みは？

4.デジタル治療薬市場における主要ベンダーの市場シェアは？

5.デジタル治療薬市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患や生活習慣に関連する健康問題の発生率の増加
    • 遠隔医療と遠隔診療を促進する政府の取り組み
    • ヘルスケアアプリと組み合わせたスマートフォンやタブレットの導入
  • 抑制要因
    • 新興経済諸国におけるデジタル治療薬に関する認識の低さ
  • 機会
    • デジタル治療薬におけるコンピューティングと人工知能の出現
    • デジタルヘルス事業への資金と投資の増加
  • 課題
    • データのプライバシーとセキュリティに関する問題
• 市場セグメンテーション分析
  • コンポーネント：データ分析ソフトウェアとコンプライアンスサービスの重要性の高まり
  • 応用：糖尿病や慢性呼吸器疾患におけるデジタル治療薬の採用率の向上、継続的な管理とモニタリングが必要
• 市場ディスラプション分析
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 価格分析
• 技術分析
• 特許分析
• 貿易分析
• 規制枠組みの分析

第6章 デジタル治療薬市場：コンポーネント別

• デバイス
• ソフトウェアとサービス

第7章 デジタル治療薬市場：用途別

• 循環器疾患
• 中枢神経系障害
• 慢性呼吸器疾患
• 糖尿病
• 服薬遵守
• 筋骨格障害
• 肥満
• 前糖尿病
• 禁煙

第8章 南北アメリカのデジタル治療薬市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域のデジタル治療薬市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカのデジタル治療薬市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス、2023
• 競合シナリオ分析
  • BehaVRとFern Healthが合併してRealizedCareを設立、デジタル治療薬の価値を解き放つデジタルケア管理プラットフォームを立ち上げ
  • ベター・セラピューティクス、2型糖尿病の成人患者を治療するAspyreRxTMの発売を発表
  • Lumanityがデジタル治療薬アライアンスに参加
• 戦略分析と提言

第12章 競合ポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. DIGITAL THERAPEUTICS MARKET RESEARCH PROCESS
• FIGURE 2. DIGITAL THERAPEUTICS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. DIGITAL THERAPEUTICS MARKET DYNAMICS
• FIGURE 7. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 12. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 14. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 16. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. DIGITAL THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 20. DIGITAL THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. DIGITAL THERAPEUTICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY DEVICES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY DEVICES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDER, BY REGION, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDER, BY REGION, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CHRONIC RESPIRATORY DISEASE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CHRONIC RESPIRATORY DISEASE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY DIABETES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY DIABETES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY MEDICATION ADHERENCE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY MEDICATION ADHERENCE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY MUSCULOSKELETAL DISORDER, BY REGION, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY MUSCULOSKELETAL DISORDER, BY REGION, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY OBESITY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY OBESITY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 29. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY PREDIABETES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 30. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY PREDIABETES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 31. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY SMOKING CESSATION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 32. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY SMOKING CESSATION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 33. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 34. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 35. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 36. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 37. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 38. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 39. ARGENTINA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 40. ARGENTINA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 41. ARGENTINA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 42. ARGENTINA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 43. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 44. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 45. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 46. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 47. CANADA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 48. CANADA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 49. CANADA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 50. CANADA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 51. MEXICO DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 52. MEXICO DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 53. MEXICO DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 54. MEXICO DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 55. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 56. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 57. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 58. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 59. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 60. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 62. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 64. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 66. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 67. AUSTRALIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 68. AUSTRALIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 69. AUSTRALIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 70. AUSTRALIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 71. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 72. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 73. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 74. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 75. INDIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 76. INDIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 77. INDIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 78. INDIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 79. INDONESIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 80. INDONESIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 81. INDONESIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 82. INDONESIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 83. JAPAN DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 84. JAPAN DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 85. JAPAN DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 86. JAPAN DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 87. MALAYSIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 88. MALAYSIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 89. MALAYSIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 90. MALAYSIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 91. PHILIPPINES DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 92. PHILIPPINES DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 93. PHILIPPINES DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 94. PHILIPPINES DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 95. SINGAPORE DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 96. SINGAPORE DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 97. SINGAPORE DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 98. SINGAPORE DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 99. SOUTH KOREA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 100. SOUTH KOREA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 101. SOUTH KOREA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 102. SOUTH KOREA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 103. TAIWAN DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 104. TAIWAN DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 105. TAIWAN DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 106. TAIWAN DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 107. THAILAND DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 108. THAILAND DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 109. THAILAND DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 110. THAILAND DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 111. VIETNAM DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 112. VIETNAM DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 113. VIETNAM DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 114. VIETNAM DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 115. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 116. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 117. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 118. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 119. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 120. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 121. DENMARK DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 122. DENMARK DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 123. DENMARK DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 124. DENMARK DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 125. EGYPT DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 126. EGYPT DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 127. EGYPT DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 128. EGYPT DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 129. FINLAND DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 130. FINLAND DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 131. FINLAND DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 132. FINLAND DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 133. FRANCE DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 134. FRANCE DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 135. FRANCE DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 136. FRANCE DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 137. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 138. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 139. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 140. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 141. ISRAEL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 142. ISRAEL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 143. ISRAEL DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 144. ISRAEL DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 145. ITALY DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 146. ITALY DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 147. ITALY DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 148. ITALY DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 149. NETHERLANDS DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 150. NETHERLANDS DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 151. NETHERLANDS DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 152. NETHERLANDS DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 153. NIGERIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 154. NIGERIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 155. NIGERIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 156. NIGERIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 157. NORWAY DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 158. NORWAY DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 159. NORWAY DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 160. NORWAY DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 161. POLAND DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 162. POLAND DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 163. POLAND DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 164. POLAND DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 165. QATAR DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 166. QATAR DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 167. QATAR DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 168. QATAR DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 169. RUSSIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 170. RUSSIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 171. RUSSIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 172. RUSSIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 173. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 174. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 175. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 176. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 177. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 178. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 179. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 180. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 181. SPAIN DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 182. SPAIN DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 183. SPAIN DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 184. SPAIN DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 185. SWEDEN DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 186. SWEDEN DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 187. SWEDEN DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 188. SWEDEN DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 189. SWITZERLAND DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 190. SWITZERLAND DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 191. SWITZERLAND DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 192. SWITZERLAND DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 193. TURKEY DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 194. TURKEY DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 195. TURKEY DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 196. TURKEY DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 197. UNITED ARAB EMIRATES DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 198. UNITED ARAB EMIRATES DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 199. UNITED ARAB EMIRATES DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 200. UNITED ARAB EMIRATES DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 201. UNITED KINGDOM DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 202. UNITED KINGDOM DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 203. UNITED KINGDOM DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 204. UNITED KINGDOM DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 205. DIGITAL THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 206. DIGITAL THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023

[194 Pages Report] The Digital Therapeutics Market size was estimated at USD 6.42 billion in 2023 and expected to reach USD 8.05 billion in 2024, at a CAGR 26.42% to reach USD 33.16 billion by 2030.

Digital therapeutics, abbreviated as DTx, refers to a branch of digital health that encompasses a range of software-driven therapeutic interventions designed to prevent, manage, or treat a medical disorder or disease. Digital therapeutics are developed on the basis of clinical evidence and often undergo rigorous regulatory review. They are intended to be used independently or in conjunction with traditional medical treatments, and they provide patients, healthcare providers, and payers with data-driven, personalized approaches to enhance patient care and health outcomes. The digital therapeutics market is growing with the escalation of chronic diseases, rising healthcare costs, and advancements in healthcare technologies. Increasing smartphone penetration and the acceptance of telehealth services also contribute to the adoption of this technology. The demand for personalized and preventive healthcare solutions further strengthens the market's progress. However, the market faces considerable challenges, including regulatory hurdles, patient data security concerns, and the need for clinical validation of digital therapeutic applications. Amidst these challenges, the integration of digital therapeutics with electronic health records (EHRs) and the potential of AI and machine learning pave the way for innovation and the future growth of the digital therapeutics market.

Component: Growing significance of data analysis software and compliance services

Devices in digital therapeutics are often wearables, sensors, and other types of biomedical hardware that collect patient data. These devices can track a wide array of health metrics, such as physical activity, sleep patterns, and blood glucose levels. Need-based preference in devices leans towards user-friendliness, accuracy, and seamless integration with software applications. Software & services are seen as the core of digital therapeutics. This segment consists of platforms, applications, and professional services that deliver therapeutic interventions. Preference is given to scalability, interoperability, patient engagement, and data security of software and services.

Application: Higher adoption of digital therapeutics in diabetes and chronic respiratory diseases, requiring continuous management and monitoring

Digital therapeutic solutions aimed at cardiovascular diseases often include applications that monitor heart rate, blood pressure, and cardiovascular health-related habits. Need-based preference for these solutions is high among patients with a history of heart disease and those at risk due to genetic factors or lifestyle. The central nervous system disorder application segment includes digital therapeutics for diseases including Parkinson's, Alzheimer's, depression, and ADHD. DTx solutions here aim at cognitive rehabilitation, behavior therapy, and medication management. Need-based preference is particularly strong among individuals seeking non-pharmacological interventions. Digital therapeutics in chronic respiratory diseases offer tools for asthma and COPD management, including inhaler tracking, symptom tracking, and environmental trigger alerts. These are preferred by patients needing continuous monitoring and those looking to manage disease exacerbations. Digital solutions for diabetes focus on blood glucose monitoring, insulin dosage tracking, and lifestyle coaching. Preference for diabetes management apps is high owing to the need for daily management and monitoring. Medication adherence applications of DTx aim to tackle the challenge of patients not taking their medications as prescribed. This need is ubiquitous across all patient categories but is particularly critical in the management of chronic diseases. Digital therapeutics for musculoskeletal disorders offer exercise programs, pain management techniques, and physical therapy guidance. They are highly preferred by patients seeking remote or supplemental treatment to traditional therapy. Digital therapeutic strategies for obesity include personalized nutrition, physical activity tracking, and behavior modification programs. The need in this segment is driven by the global rise in obesity rates and the associated health risks. Digital therapeutics for prediabetes focus on lifestyle interventions to prevent the onset of type 2 diabetes. These applications are useful for individuals identified as having prediabetes to delay or prevent disease progression. For smoking cessation, digital therapeutics include quit plans, tracking of progress, and counseling support. These tools have a high preference among those trying to quit smoking, often complementing nicotine replacement therapies.

Regional Insights

In the Americas, the market for digital therapeutics is robust, underpinned by progressive regulatory frameworks, significant venture capital investments, and growing partnerships between DTx companies and healthcare providers. The United States Food and Drug Administration (FDA) has been creating a conducive environment for DTx products through clear guidance and approvals for prescription DTx, which are seen as important steps toward integrating these solutions into standard healthcare practices. Europe's digital therapeutics market is marked by a strong emphasis on evidence-based solutions and is driven by a diverse healthcare landscape where countries are adopting various approaches to integrate DTx into their healthcare systems. Initiatives such as Germany's Digital Healthcare Act (DVG), which allows doctors to prescribe digital health applications, exemplify the supportive regulatory environment. The Middle East and Africa, while still at nascent stages, are expected to witness growth, largely propelled by mobile-based health initiatives and partnerships aiming to improve access to healthcare services. The APAC region shows vast potential for digital therapeutics, although the market presents a heterogeneous mix of economic, cultural, and technological readiness. Countries, including Japan and Singapore, are at the forefront of adopting DTx, with favorable regulatory pathways and initiatives for digital health innovation. In other areas, such as India and China, rising smartphone penetration and government initiatives to support digital health ecosystems are creating opportunities for DTx expansion.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Digital Therapeutics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Digital Therapeutics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Digital Therapeutics Market, highlighting leading vendors and their innovative profiles. These include 2morrow Inc., Akili Interactive Labs, Inc., Ayogo Health Inc., Better Therapeutics, Inc., Big Health, Inc., Biofourmis Inc., Canary Health Technologies Inc., Click Therapeutics, Inc., Cognoa, Inc., DarioHealth Corp., Fern Health, Inc., Fitterfly Healthtech Private Limited, Happify, Inc., Headspace Inc., Kaia Health Software Inc., Lark Technologies, Inc., Lumanity Inc., MedRhythms, Noom, Inc., Omada Health Inc., Pear Therapeutics, Inc., Propeller Health by ResMed Corp., SilverCloud by American Well Corporation, Voluntis by AptarGroup, Inc., and Welldoc, Inc..

Market Segmentation & Coverage

This research report categorizes the Digital Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Component
  • Devices
  • Software & Services

• Application
  • Cardiovascular Disease
  • Central Nervous System Disorder
  • Chronic Respiratory Disease
  • Diabetes
  • Medication Adherence
  • Musculoskeletal Disorder
  • Obesity
  • Prediabetes
  • Smoking Cessation

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Digital Therapeutics Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Digital Therapeutics Market?

3. What are the technology trends and regulatory frameworks in the Digital Therapeutics Market?

4. What is the market share of the leading vendors in the Digital Therapeutics Market?

5. Which modes and strategic moves are suitable for entering the Digital Therapeutics Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing incidences of chronic diseases and lifestyle-related health issues
    • 5.1.1.2. Government initiatives promoting telehealth and telemedicine
    • 5.1.1.3. Adoption of smartphones and tablets coupled with healthcare apps
  • 5.1.2. Restraints
    • 5.1.2.1. Limited awareness regarding digital therapeutics in developing economies
  • 5.1.3. Opportunities
    • 5.1.3.1. Advent of computing and artificial intelligence in digital therapeutics
    • 5.1.3.2. Rising funding and investments for digital health businesses
  • 5.1.4. Challenges
    • 5.1.4.1. Issues pertaining to data privacy and security
• 5.2. Market Segmentation Analysis
  • 5.2.1. Component: Growing significance of data analysis software and compliance services
  • 5.2.2. Application: Higher adoption of digital therapeutics in diabetes and chronic respiratory diseases, requiring continuous management and monitoring
• 5.3. Market Disruption Analysis
• 5.4. Porter's Five Forces Analysis
  • 5.4.1. Threat of New Entrants
  • 5.4.2. Threat of Substitutes
  • 5.4.3. Bargaining Power of Customers
  • 5.4.4. Bargaining Power of Suppliers
  • 5.4.5. Industry Rivalry
• 5.5. Value Chain & Critical Path Analysis
• 5.6. Pricing Analysis
• 5.7. Technology Analysis
• 5.8. Patent Analysis
• 5.9. Trade Analysis
• 5.10. Regulatory Framework Analysis

6. Digital Therapeutics Market, by Component

• 6.1. Introduction
• 6.2. Devices
• 6.3. Software & Services

7. Digital Therapeutics Market, by Application

• 7.1. Introduction
• 7.2. Cardiovascular Disease
• 7.3. Central Nervous System Disorder
• 7.4. Chronic Respiratory Disease
• 7.5. Diabetes
• 7.6. Medication Adherence
• 7.7. Musculoskeletal Disorder
• 7.8. Obesity
• 7.9. Prediabetes
• 7.10. Smoking Cessation

8. Americas Digital Therapeutics Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Digital Therapeutics Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Digital Therapeutics Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
  • 11.3.1. BehaVR and Fern Health Merge To Form RealizedCare, Launch Digital Care Management Platform to Unlock the Value of Digital Therapeutics
  • 11.3.2. Better Therapeutics Announces Launch of AspyreRxTM to Treat Adults with Type 2 Diabetes
  • 11.3.3. Lumanity Joins The Digital Therapeutics Alliance
• 11.4. Strategy Analysis & Recommendation

12. Competitive Portfolio

• 12.1. Key Company Profiles
• 12.2. Key Product Portfolio